Presenting Sponsor: Takeda
Subscribe to BloodStream Podcast: Link
BioMarin plans return to FDA with updated data on hemophilia gene therapy (BioPharmaDive): Link
BioMarin's hemophilia A gene therapy hits goal in phase 3, teeing up FDA filing despite durability doubts (Fierce Biotech): Link
Connect with BloodStream Media:
Presenting Sponsor: Takeda
Subscribe to BloodStream Podcast: Link
Buffalo New Obituary
Val Bias, 63, crusader for better care for those with hemophilia and HIV/AIDS: LINK
World Federation of Hemophilia
WFH VP Medical Glenn Pierce pays tribute to Val Bias: LINK
National Hemophilia Foundation
NHF Mourns the Loss of Longtime CEO, Val Bias: LINK
Connect with BloodStream Media:
We hear from Save One Life and the World Federation of Hemophilia on what to expect in 2022, as well as some gene therapy trial updates. Patrick and Amy speak about the loss of Val Bias and preview a special episode honoring his life.
Show Notes:
Presenting Sponsor: Takeda
Subscribe to BloodStream Podcast: Link
Connect with BloodStream Media: